CTL derived from (C3H x B6.K1)F1 animals were sensitized against L cells that express the transfected gene product Q10d/Ld. These CTL were highly crossreactive against three other class I molecules, H-2Kbm1, H-2Ld, and H-2Kd. In an attempt to define this crossreactive epitope it was noted that between 25 and 39% of amino acids in the alpha helices and central beta strands of these three molecules vary from Q10d. These amino acids represent residues that have been proposed to potentially interact with a peptide antigen or TCR (21). However, all four molecules share the amino acid tyrosine at positions 155 and 156. Additionally, Q10d, H-2Kbm1, and H-2Ld share alanine at position 152, while H-2Kd has an aspartic acid. We showed that these residues were important in controlling this epitope by the finding that anti-Q10d CTL did not recognize H-2Kbm1 revertant molecules that had either the position 152 alanine changed back to the wild-type H-2Kb residue (glutamic acid) or position 155 and 156 tyrosines changed back to wild-type residues arginine and leucine. Further evidence that these molecules share a crossreactive epitope was noted by the failure of (C3H x H-2Kbm1)F1 animals to generate CTL that recognized H-2Ld or H-2Kd, and the inability of (C3H x BALB/c)F1 animals to generate CTL reactive against H-2Kbm1. CTL from these mice were still able to recognize Q10d/Ld indicating that other epitopes could be detected if natural tolerance prevented recognition of the crossreactive epitope. To further define the epitope, CTL clones were generated against Q10d/Ld and maintained on either H-2Kbm1 or BALB/c feeder cells. In addition to testing these clones on the target cells described above, mutant molecules derived from H-2Ld, which have amino acid substitutions in their alpha 1 domain, were analyzed. It was noted that some anti-Q10 clones that did not crossreact on H-2Ld did react against H-2Ld mutant antigens that had H-2Dd amino acid substitutions in the alpha 1 domain at positions 63, 65, 66, and 70. Other clones had differential reactivities on these H-2Ld mutants further substantiating that alpha 1 domain amino acids play a role in controlling the expression of the crossreactive epitope. Thus, four class I molecules with multiple amino acid differences in their alpha 1 and alpha 2 domains share a crossreactive epitope readily recognized by alloreactive CTL.(ABSTRACT TRUNCATED AT 250 WORDS)
Skip Nav Destination
Article navigation
1 July 1988
Article|
July 01 1988
An immunodominant epitope present in multiple class I MHC molecules and recognized by cytotoxic T lymphocytes.
D W Mann,
D W Mann
Department of Microbiology, University of Texas Southwestern Medical Center, Dallas 75235.
Search for other works by this author on:
E McLaughlin-Taylor,
E McLaughlin-Taylor
Department of Microbiology, University of Texas Southwestern Medical Center, Dallas 75235.
Search for other works by this author on:
R B Wallace,
R B Wallace
Department of Microbiology, University of Texas Southwestern Medical Center, Dallas 75235.
Search for other works by this author on:
J Forman
J Forman
Department of Microbiology, University of Texas Southwestern Medical Center, Dallas 75235.
Search for other works by this author on:
D W Mann
Department of Microbiology, University of Texas Southwestern Medical Center, Dallas 75235.
E McLaughlin-Taylor
Department of Microbiology, University of Texas Southwestern Medical Center, Dallas 75235.
R B Wallace
Department of Microbiology, University of Texas Southwestern Medical Center, Dallas 75235.
J Forman
Department of Microbiology, University of Texas Southwestern Medical Center, Dallas 75235.
Online ISSN: 1540-9538
Print ISSN: 0022-1007
J Exp Med (1988) 168 (1): 307–324.
Citation
D W Mann, E McLaughlin-Taylor, R B Wallace, J Forman; An immunodominant epitope present in multiple class I MHC molecules and recognized by cytotoxic T lymphocytes.. J Exp Med 1 July 1988; 168 (1): 307–324. doi: https://doi.org/10.1084/jem.168.1.307
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement